Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Hospitals Communication Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 30, 2025

How will RFK Jr’s American dream for vaccines play out? It limits the access of approved drugs to certain hospitals and clinics that had to be specially certified for therapy administration and have access to anti-inflammatory medication. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Labelling Communication 52

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. MAXSHOT.PL via Shutterstock.

Labelling 52

Labelling Vaccines Insurance Coverage and Processing Packaging 52

Pharmaceutical Technology

JULY 9, 2025

How will RFK Jr’s American dream for vaccines play out? Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? The company is confident that these concerns, which pertain to facilities and processes rather than product quality, can be promptly addressed. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Packaging Hospitals 52

Pharmaceutical Technology

JUNE 16, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Communication Hospitals Vaccines 98

Pharmaceutical Technology

JUNE 20, 2025

Unlike vaccines, the agency leaders see the modality as a path to prevent and cure disease – aligning with the current administration’s wider national health strategy. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. Until now, the vaccine was licensed for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 years and older.

Vaccines 52

Vaccines Insurance Coverage and Processing Labelling Communication 52

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. lev radin via Shutterstock. lev radin via Shutterstock. Data Insights The gold standard of business intelligence.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunization 52

STAT

AUGUST 17, 2023

Bancel is in the process of donating a vast majority of his income to charities. That CEO haul was down 11% from the $4.5 billion recorded in 2021. The 10 highest-paid CEOs — a list that also includes the CEOs of Thermo Fisher and McKesson — made a combined $1.4 billion, or about a third of the total studied.

Insurance Coverage and Processing 246

Insurance Coverage and Processing Nursing Homes Prescription Filling Hospitals 246

The Digital Apothecary

AUGUST 15, 2017

Pharmacy has drastically changed, and with the patient view of most pharmacists just 'Count-Lick-and Pour' medications for patients it's not hard then to think of how to just automate the process. One issue is that the dispensing process is not a full-proof system at the current time. Which, to be honest, is a thing right now.

Mail-Order Pharmacies 130

Mail-Order Pharmacies Insurance Coverage and Processing Health and Personal Care Stores Medication Dispensing 130

Express Pharma

JANUARY 12, 2024

Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India. For pharma and medical devices policies, the Department of Pharmaceutical is the nodal agency. –

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Health Insurance Companies 52

pharmaphorum

JULY 19, 2021

Now, as vaccination continues at pace, the sector has pledged to help “build back better”, by lowering barriers between medical innovations and the patients who need them. As this report demonstrates, the biopharmaceutical indusyry is ready and willing to play its part in this process. Healthy diversity and inclusion. About the author.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Vaccines Documentation Immunization 105

Community Pharmacy

NOVEMBER 15, 2022

If this applies to you, then you can begin your application process here to get the process started. Medicare Part D has four phases of coverage that users need to be aware of before and during enrollment in the program. In 2022, the initial coverage limit was $4,430. In 2022, the coverage gap limit was $7,050.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Community Pharmacies Vaccines Hospitals 52

Putting Patients First Blog

MARCH 29, 2023

They primarily focus on improving the public health infrastructure, improving the development of treatment and vaccines, and coordinating federal response. These flexibilities and partnerships greatly increased the speed of research and development for COVID-19 testing, treatment, and vaccines.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Vaccines Documentation Hospitals 40

Putting Patients First Blog

SEPTEMBER 9, 2024

19 Telehealth reduces the need for costly emergency room visits and hospitalizations by providing patients with convenient access to preventive care and early intervention services. Providing clear guidance, technical assistance, and streamlined processes can help facilitate the adoption of this innovative care model.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Documentation Vaccines Communication 40

Express Pharma

FEBRUARY 1, 2025

The announcement to set up Day Care Cancer Centres in all district hospitals over the next three yearsstarting with 200 in 2025-26is a commendable step in strengthening cancer care infrastructure. The recommendation to allow up to 100 per cent FDI in insurance can be a complementary to the focus on enhancing access to cancer care.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Hospitals Vaccines 52